These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

420 related items for PubMed ID: 11286843

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Clinical implications of incomplete repair parameters for rat spinal cord: the feasibility of large doses per fraction in PDR and HDR brachytherapy.
    Pop LA, Millar WT, Visser AG, van der Kogel AJ.
    Int J Radiat Oncol Biol Phys; 2001 Sep 01; 51(1):215-26. PubMed ID: 11516872
    [Abstract] [Full Text] [Related]

  • 4. The optimal fraction size in high-dose-rate brachytherapy: dependency on tissue repair kinetics and low-dose rate.
    Sminia P, Schneider CJ, Fowler JF.
    Int J Radiat Oncol Biol Phys; 2002 Mar 01; 52(3):844-9. PubMed ID: 11849810
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [In vitro studies of PDR brachytherapy].
    Fritz P, Frank C, Weber KJ.
    Strahlenther Onkol; 1998 Jul 01; 174(7):365-74. PubMed ID: 9689958
    [Abstract] [Full Text] [Related]

  • 7. Is pulsed dose rate more damaging to spinal cord of rats than continuous low dose rate?
    Haustermans K, Fowler J, Landuyt W, Lambin P, van der Kogel A, van der Schueren E.
    Radiother Oncol; 1997 Oct 01; 45(1):39-47. PubMed ID: 9364630
    [Abstract] [Full Text] [Related]

  • 8. High-dose-rate brachytherapy may be radiobiologically superior to low-dose rate due to slow repair of late-responding normal tissue cells.
    Orton CG.
    Int J Radiat Oncol Biol Phys; 2001 Jan 01; 49(1):183-9. PubMed ID: 11163513
    [Abstract] [Full Text] [Related]

  • 9. Radiation tolerance of rat spinal cord to pulsed dose rate (PDR-) brachytherapy: the impact of differences in temporal dose distribution.
    Pop LA, Millar WT, van der Plas M, van der Kogel AJ.
    Radiother Oncol; 2000 Jun 01; 55(3):301-15. PubMed ID: 10869745
    [Abstract] [Full Text] [Related]

  • 10. Constraints in the use of repair half times and mathematical modelling for the clinical application of HDR and PDR treatment schedules as an alternative for LDR brachytherapy.
    Pop LA, van den Broek JF, Visser AG, van der Kogel AJ.
    Radiother Oncol; 1996 Feb 01; 38(2):153-62. PubMed ID: 8966228
    [Abstract] [Full Text] [Related]

  • 11. Low-dose-rate brachytherapy is superior to high-dose-rate brachytherapy for bladder cancer.
    Pos FJ, Horenblas S, Lebesque J, Moonen L, Schneider C, Sminia P, Bartelink H.
    Int J Radiat Oncol Biol Phys; 2004 Jul 01; 59(3):696-705. PubMed ID: 15183473
    [Abstract] [Full Text] [Related]

  • 12. Comparison between fractionated high dose rate irradiation and continuous low dose rate irradiation in spheroids.
    Omura M, Torigoe S, Kurihara H, Matsubara S, Kubota N.
    Acta Oncol; 1998 Jul 01; 37(7-8):681-6. PubMed ID: 10050987
    [Abstract] [Full Text] [Related]

  • 13. The irradiation tolerance dose of the proximal vagina.
    Au SP, Grigsby PW.
    Radiother Oncol; 2003 Apr 01; 67(1):77-85. PubMed ID: 12758243
    [Abstract] [Full Text] [Related]

  • 14. Interstitial hyperthermia and interstitial radiotherapy of a rat rhabdomyosarcoma; effects of sequential treatment and consequences for clonogenic repopulation.
    van Geel CA, Visser AG, van Hooije CM, van den Aardweg GJ, Kolkman-Deurloo IK, Kaatee RS, Levendag PC.
    Int J Hyperthermia; 1994 Apr 01; 10(6):835-44. PubMed ID: 7884243
    [Abstract] [Full Text] [Related]

  • 15. Radiobiologic studies of radioimmunotherapy and external beam radiotherapy in vitro and in vivo in human renal cell carcinoma xenografts.
    Ning S, Trisler K, Wessels BW, Knox SJ.
    Cancer; 1997 Dec 15; 80(12 Suppl):2519-28. PubMed ID: 9406705
    [Abstract] [Full Text] [Related]

  • 16. LDR vs. HDR brachytherapy for localized prostate cancer: the view from radiobiological models.
    King CR.
    Brachytherapy; 2002 Dec 15; 1(4):219-26. PubMed ID: 15062170
    [Abstract] [Full Text] [Related]

  • 17. Patterns of brachytherapy practice for patients with carcinoma of the cervix (1996-1999): a patterns of care study.
    Erickson B, Eifel P, Moughan J, Rownd J, Iarocci T, Owen J.
    Int J Radiat Oncol Biol Phys; 2005 Nov 15; 63(4):1083-92. PubMed ID: 16099599
    [Abstract] [Full Text] [Related]

  • 18. Radiobiological equivalent of low/high dose rate brachytherapy and evaluation of tumor and normal responses to the dose.
    Manimaran S.
    Radiat Med; 2007 Jun 15; 25(5):229-35. PubMed ID: 17581712
    [Abstract] [Full Text] [Related]

  • 19. High-dose-rate versus low-dose-rate brachytherapy in the treatment of cervical cancer: analysis of tumor recurrence--the University of Wisconsin experience.
    Petereit DG, Sarkaria JN, Potter DM, Schink JC.
    Int J Radiat Oncol Biol Phys; 1999 Dec 01; 45(5):1267-74. PubMed ID: 10613322
    [Abstract] [Full Text] [Related]

  • 20. Biological effect of pulsed dose rate brachytherapy with stepping sources if short half-times of repair are present in tissues.
    Fowler JF, Van Limbergen EF.
    Int J Radiat Oncol Biol Phys; 1997 Mar 01; 37(4):877-83. PubMed ID: 9128965
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.